Mesalamine Tablet, Delayed Release
FDA Label NDC 70771-1071

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Mesalamine (NDC 70771-1071). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1071-1

Mesalamine Delayed-release Tablets, 1.2 g

Rx only

120 tablets

Mesalamine Dr Tablets, 1.2 G (Fbca41b2 19be 4a61 96d9 D75fb72d8474 01)

Mesalamine Dr Tablets, 1.2 G (Fbca41b2 19be 4a61 96d9 D75fb72d8474 01)

* Please review the disclaimer below.